Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Accenture
Baxter
Medtronic
Healthtrust
Dow
McKinsey
Julphar

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016320

« Back to Dashboard

NDA 016320 describes MYAMBUTOL, which is a drug marketed by Sti Pharma Llc and is included in one NDA. It is available from eight suppliers. Additional details are available on the MYAMBUTOL profile page.

The generic ingredient in MYAMBUTOL is ethambutol hydrochloride. There are five drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ethambutol hydrochloride profile page.
Summary for 016320
Tradename:MYAMBUTOL
Applicant:Sti Pharma Llc
Ingredient:ethambutol hydrochloride
Patents:0
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 016320
Medical Subject Heading (MeSH) Categories for 016320
Suppliers and Packaging for NDA: 016320
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MYAMBUTOL ethambutol hydrochloride TABLET;ORAL 016320 NDA A-S Medication Solutions 50090-0417 N 50090-0417-2
MYAMBUTOL ethambutol hydrochloride TABLET;ORAL 016320 NDA State of Florida DOH Central Pharmacy 53808-0977 E 53808-0977-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength400MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Teva
Fish and Richardson
Accenture
Baxter
Moodys
Deloitte
Citi
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.